1. Home
  2. AUR vs RGEN Comparison

AUR vs RGEN Comparison

Compare AUR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Innovation Inc.

AUR

Aurora Innovation Inc.

HOLD

Current Price

$4.91

Market Cap

11.7B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$175.52

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUR
RGEN
Founded
2017
1981
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
11.0B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
AUR
RGEN
Price
$4.91
$175.52
Analyst Decision
Buy
Buy
Analyst Count
13
22
Target Price
$12.13
★ $197.95
AVG Volume (30 Days)
★ 22.2M
1.2M
Earning Date
10-28-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
4.35
★ 286.96
EPS
N/A
★ 0.24
Revenue
$3,000,000.00
★ $141,236,000.00
Revenue This Year
$399.72
$12.87
Revenue Next Year
$1,152.29
$29.67
P/E Ratio
★ N/A
$738.08
Revenue Growth
N/A
★ 35.10
52 Week Low
$3.60
$100.99
52 Week High
$8.57
$198.87

Technical Indicators

Market Signals
Indicator
AUR
RGEN
Relative Strength Index (RSI) 34.89 48.17
Support Level $4.79 $158.62
Resistance Level $5.02 $187.36
Average True Range (ATR) 0.29 8.73
MACD -0.04 -0.39
Stochastic Oscillator 20.32 48.44

Price Performance

Historical Comparison
AUR
RGEN

About AUR Aurora Innovation Inc.

Aurora Innovation is a US autonomous driving provider for heavy trucks. The company produces and sells its Aurora Driver system, which includes hardware installed in a vehicle, software to autonomously drive it, and data management to maintain and improve the software. Aurora targets long-haul routes. The company currently offers its trucking-as-a-service model, where it owns and operates the trucks and makes deliveries for customers. The company plans to start selling its driver-as-a-service model next year, where fleet owners will own the trucks and Aurora's software will operate them.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: